| RS2152258991 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2152270212 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial calcification, generalized |
| RS2152278559 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152281284 |
MEF2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2152283906 |
ABCC6
|
Health Risk |
Likely pathogenic |
— |
| RS2152284932 |
TRIO
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 63 |
| RS2152285036 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2152289369 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152289454 |
EVC
|
Health Risk |
Likely pathogenic |
— |
| RS2152290090 |
TRIO
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS2152305937 |
TRIO
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 63 |
| RS2152325575 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152326431 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152326471 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152326510 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152326544 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152326727 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS2152326770 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152328249 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS2152328365 |
ALDH3A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152328724 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152328735 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2152328756 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS2152329943 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2152330714 |
ALDH3A2
|
Health Risk |
Likely pathogenic |
— |
| RS2152331137 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2152331147 |
ALDH3A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS2152333224 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS2152335941 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS2152340509 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152340689 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS2152340697 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2152340942 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152344481 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS2152345583 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152348001 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS2152351208 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS2152354197 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2152362140 |
EVC
|
Health Risk |
Likely pathogenic |
— |
| RS2152363791 |
TRIO
|
Health Risk |
Conflicting classifications of pathogenicity |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2152363798 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS2152370482 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2152373759 |
TRIO
|
Health Risk |
Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS2152373800 |
TRIO
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2152375194 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152375437 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152382691 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Hereditary sensory and autonomic neuropathy type 6 |
| RS2152383049 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152385271 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2152387124 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152387847 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152387946 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152388054 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS2152391901 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS2152392855 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152392876 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152392902 |
LOC130059818;SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152394710 |
DST
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2152400490 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152400493 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152402048 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152402791 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152403168 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2152403446 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152403474 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152403519 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152403759 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152409202 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2152409901 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152410293 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152411067 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152411070 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152412161 |
SPG7
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152412171 |
SPG7
|
Health Risk |
Likely pathogenic |
— |
| RS2152412388 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS2152417708 |
THUMPD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder with speech delay and variable ocular anomalies |
| RS2152417882 |
THUMPD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder with speech delay and variable ocular anomalies |
| RS2152417926 |
THUMPD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2152419456 |
THUMPD1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder with speech delay and variable ocular anomalies |
| RS2152422891 |
DST
|
Health Risk |
Likely pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2152427474 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2152440123 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2152474705 |
BRCA1
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Breast-ovarian cancer |
| RS2152476215 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2152478652 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152478688 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152478820 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2152486042 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2152497250 |
MEF2C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, stereotypic hand movements |
| RS2152501157 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS2152505917 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152506082 |
DST
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2152507134 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152514800 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152514807 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152514867 |
SNHG14;UBE3A
|
Health Risk |
Likely pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152515149 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152515439 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2152515457 |
UBE3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2152522245 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |